Should you buy China Biologic Products Holdings stock? (NasdaqGS:CBPO). Let's see how it does in our automated value investing analysis system.
Based on historical returns, we believe that China Biologic Products Holdings can grow its free cash at a rate of about 7%. That's positive!
(China Biologic Products Holdings stock price per share)
||CBPO Fair Price
(based on intrinsic value)
||CBPO Safety Price (based on a variable margin of safety)||$16.76|
||PE Ratio versus Sector||77% higher than other Healthcare stocks|
|PE Ratio versus Industry||37% lower than other Biotechnology stocks|
|Free Cash Flow Jitter||25%|
We believe that China Biologic Products Holdings may be worth examining further. It's making money, which is a very positive sign. Is it on sale?
China Biologic Products Holdings looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.
Does China Biologic Products Holdings have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
Most Popular Articles